USANA Health Sciences Inc (USNA) stock
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.22−0.35 (-2.58%)
Close on Nov 18, 2026Market cap $244.26MP/E –Yield –
USANA Health Sciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
USANA Health Sciences's revenue for the twelve months ending Jul 4, 2026 was $913.36M, up 1.6% year over year. For fiscal 2025 it was $925.26M, up 8.3% from the year before. Over ten years it grew 0.1% a year on average. The highest annual figure on record is $1.19B in fiscal 2018.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $925.26M | +8.3% |
| FY2024 | Dec 28, 2024 | $854.50M | -7.2% |
| FY2023 | Dec 30, 2023 | $921.01M | -7.8% |
| FY2022 | Dec 31, 2022 | $998.60M | -15.8% |
| FY2021 | Jan 1, 2022 | $1.19B | +4.6% |
| FY2020 | Jan 2, 2021 | $1.13B | +7.0% |
| FY2019 | Dec 28, 2019 | $1.06B | -10.8% |
| FY2018 | Dec 29, 2018 | $1.19B | +13.6% |
| FY2017 | Dec 30, 2017 | $1.05B | +4.1% |
| FY2016 | Dec 31, 2016 | $1.01B | +9.5% |
| FY2015 | Jan 2, 2016 | $918.50M | +16.2% |
| FY2014 | Jan 3, 2015 | $790.47M | +10.1% |
| FY2013 | Dec 28, 2013 | $718.18M | +10.7% |
| FY2012 | Dec 29, 2012 | $648.73M | +11.5% |
| FY2011 | Dec 31, 2011 | $581.94M | +12.4% |
| FY2010 | Jan 1, 2011 | $517.64M | +18.5% |
| FY2009 | Jan 2, 2010 | $436.94M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 4, 2026 | $223.27M | -5.3% |
| Q1 FY2026 | Apr 4, 2026 | $250.22M | +0.3% |
| Q4 FY2025 | Jan 3, 2026 | $226.20M | +5.9% |
| Q3 FY2025 | Sep 27, 2025 | $213.67M | +6.7% |
| Q2 FY2025 | Jun 28, 2025 | $235.85M | +10.8% |
| Q1 FY2025 | Mar 29, 2025 | $249.54M | +9.5% |
| Q4 FY2024 | Dec 28, 2024 | $213.61M | -3.4% |
| Q3 FY2024 | Sep 28, 2024 | $200.22M | -6.2% |
| Q2 FY2024 | Jun 29, 2024 | $212.87M | -10.6% |
| Q1 FY2024 | Mar 30, 2024 | $227.80M | -8.3% |
| Q4 FY2023 | Dec 30, 2023 | $221.08M | -3.0% |
| Q3 FY2023 | Sep 30, 2023 | $213.37M | -8.5% |
| Q2 FY2023 | Jul 1, 2023 | $238.20M | -9.9% |
| Q1 FY2023 | Apr 1, 2023 | $248.36M | -9.0% |
| Q4 FY2022 | Dec 31, 2022 | $227.96M | -14.7% |
| Q3 FY2022 | Oct 1, 2022 | $233.30M | -15.0% |
| Q2 FY2022 | Jul 2, 2022 | $264.47M | -21.5% |
| Q1 FY2022 | Apr 2, 2022 | $272.87M | -11.4% |
| Q4 FY2021 | Jan 1, 2022 | $267.30M | -13.9% |
| Q3 FY2021 | Oct 2, 2021 | $274.35M | -8.1% |
| Q2 FY2021 | Jul 3, 2021 | $336.84M | +30.1% |
| Q1 FY2021 | Apr 3, 2021 | $307.98M | +15.5% |
| Q4 FY2020 | Jan 2, 2021 | $310.52M | +14.5% |
| Q3 FY2020 | Sep 26, 2020 | $298.51M | +14.5% |
| Q2 FY2020 | Jun 27, 2020 | $258.99M | +1.2% |
| Q1 FY2020 | Mar 28, 2020 | $266.62M | -2.3% |
| Q4 FY2019 | Dec 28, 2019 | $271.30M | -9.3% |
| Q3 FY2019 | Sep 28, 2019 | $260.60M | -12.2% |
| Q2 FY2019 | Jun 29, 2019 | $256.02M | -15.1% |
| Q1 FY2019 | Mar 30, 2019 | $272.99M | -6.5% |
| Q4 FY2018 | Dec 29, 2018 | $299.02M | +9.5% |
| Q3 FY2018 | Sep 29, 2018 | $296.77M | +13.4% |
| Q2 FY2018 | Jun 30, 2018 | $301.46M | +17.3% |
| Q1 FY2018 | Mar 31, 2018 | $292.00M | +14.4% |
| Q4 FY2017 | Dec 30, 2017 | $273.11M | +8.0% |
| Q3 FY2017 | Sep 30, 2017 | $261.77M | +3.0% |
| Q2 FY2017 | Jul 1, 2017 | $257.06M | – |
| Q1 FY2017 | Apr 1, 2017 | $255.32M | – |
| Q4 FY2016 | Dec 31, 2016 | $252.90M | – |
| Q3 FY2016 | Oct 1, 2016 | $254.22M | – |
See a number that looks wrong?